DekaBank Deutsche Girozentrale Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

DekaBank Deutsche Girozentrale boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 2.5% in the fourth quarter, Holdings Channel.com reports. The fund owned 296,567 shares of the biotechnology company’s stock after buying an additional 7,280 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in BioMarin Pharmaceutical were worth $30,273,000 as of its […]

Related Keywords

United States ,America ,Dekabank Deutsche Girozentrale ,Johnc Klock ,Jean Jacques Bienaime ,Jeffrey Robert Ajer ,Stifel Nicolaus ,Morgan Stanley ,Allspring Global Investments Holdings ,Securities Exchange Commission ,Exchange Commission ,Holdings Channel ,Nasdaq ,Biomarin Pharmaceutical Inc ,Polar Capital Holdings Plc ,Biomarin Pharmaceutical ,Get Rating ,Bank Deutsche Girozentrale ,Global Investments Holdings ,Capital Holdings Plc ,Two Sigma Investments ,Sigma Investments ,Robert Ajer ,Jacques Bienaime ,Marin Pharmaceutical ,Visit Holdingschannel ,Biomarin Pharmaceutical Daily ,Nasdaq Bmrn ,Bmrn ,Medical ,09061g10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,